Obesity, inflammation and type II diabetes

被引：15

作者：

Finegood, DT ^{[1
]}

机构：

[1] Simon Fraser Univ, Canadian Inst Hlth Res, Inst Nutr Metab & Diabet, Burnaby, BC V5A 1S6, Canada

来源：

INTERNATIONAL JOURNAL OF OBESITY | 2003年 / 27卷 / Suppl 3期

关键词：

D O I：

10.1038/sj.ijo.0802490

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：S4 / S5

页数：2

共 5 条

[1] ASSESSMENT OF INSULIN SENSITIVITY INVIVO [J].

BERGMAN, RN ;

FINEGOOD, DT ;

ADER, M .

ENDOCRINE REVIEWS, 1985, 6 (01) :45-86

[2] β-cell mass dynamics in Zucker diabetic fatty rats -: Rosiglitazone prevents the rise in net cell death [J].

Finegood, DT ;

McArthur, MD ;

Kojwang, D ;

Thomas, MJ ;

Topp, BG ;

Leonard, T ;

Buckingham, RE .

DIABETES, 2001, 50 (05) :1021-1029

[3] ADIPOSE EXPRESSION OF TUMOR-NECROSIS-FACTOR-ALPHA - DIRECT ROLE IN OBESITY-LINKED INSULIN RESISTANCE [J].

HOTAMISLIGIL, GS ;

SHARGILL, NS ;

SPIEGELMAN, BM .

SCIENCE, 1993, 259 (5091) :87-91

[4]

Katzmarzyk PT, 2002, CAN MED ASSOC J, V166, P1039

[5] The spread of the obesity epidemic in the United States, 1991-1998 [J].

Mokdad, AH ;

Serdula, MK ;

Dietz, WH ;

Bowman, BA ;

Marks, JS ;

Koplan, JP .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (16) :1519-1522

← 1 →